NightWare and Cardiovascular Health in Women With PTSD
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT07021014
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Autonomic Dysfunction
- Cardiovascular Diseases
- Endothelial Dysfunction
- Kidney Diseases
- Nightmare
- Post Traumatic Stress Disorder
- Renal Dysfunction
- Trauma and Stressor Related Disorders
- Vascular Stiffness
Eligibility Criteria
- Sex
- FEMALE
- Age
- 22 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- NightWare — DEVICEA wearable digital therapeutic platform consisting of an Apple Watch and iPhone pre-provisioned with Nightware intervention app that will deliver a mild vibration to the watch after detecting individual having a nightmare based on Nightware proprietary algorithm, arousing the individual and disrupting nightmare without awakening.
- Sham NightWare — DEVICENightWare decive will not deliver an intervention (i.e., no vibration)
Study Details
The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular and renal function in premenopausal women with PTSD-related nightmares, and examine whether these improvements restore them to levels observed in age-matched women without PTSD.
Key Dates
- Start date
- Jul 31, 2025
- Status verified
- Jun 2025
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental NightWareIn women with PTSD-related nightmares randomized to the active condition, when the stress index is reached during sleep, NightWare will intervene with varying degrees of vibratory stimulation to the watch over a variable length of time to arouse the person out of the nightmare without awakening.
- Sham Comparator: Sham NightWareIn women with PTSD-related nightmares randomized to the sham condition, the NightWare intervention will not be enabled
- No Intervention: Control Women without PTSD-related NightmaresAge-matched women without PTSD-related nightmares will complete baseline testing only (no intervention).
Primary Outcome Measure
Brachial artery flow-mediated dilation (FMD) [ Time Frame: PTSD vs controls at baseline. In PTSD group only, change with NightWare vs Sham (measured before and after 8 weeks of NightWare or sham conditions). ]
Central Contacts
- Emily Larson, PhD7205233224
- Kerrie Moreau, PhD
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | |
| University of Colorado CCTSI CTRC | Denver | Colorado | 80045 |
Find similar trials in Aurora, CO
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Bright Light Exposure in Surgical PatientsRecruiting · University of Colorado, Denver · Denver, Colorado
- Puberty Suppression and Cardiometabolic HealthRecruiting · University of Colorado, Denver · Aurora, Colorado